Biocontainment Research Support Service(s) Core
生物防护研究支持服务核心
基本信息
- 批准号:10793952
- 负责人:
- 金额:$ 78.33万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-08-18 至 2028-07-31
- 项目状态:未结题
- 来源:
- 关键词:Animal ModelAntibiotic ResistanceArticulationBacillus anthracisBiochemicalBiological AssayBiological ProductsCellsChargeChicagoCollaborationsCommunitiesConsultationsContainmentDataDevelopmentDiagnosticDrug ScreeningEmergency responseEmerging Communicable DiseasesEnsureEnvironmentEquipmentEventGeneticGoalsGrowthGuidelinesHealthImmune responseImmunizationIn VitroInfectionInfectious Diseases ResearchInfrastructureInstitutionInstructionKnowledgeLaboratoriesLeadLearningMeasuresMicrobeMissionMycobacterium tuberculosisNamesPhenotypeProcessProtocols documentationRNA VirusesReportingResearchResearch PersonnelResearch SupportResearch TrainingResistance profileRickettsiaSecureServicesSisterSpecimenStandardizationSupervisionTechnologyTestingTherapeuticTrainingUniversitiesYersinia pestisbiocontainment facilitybiodefensebiosecuritydesignexperiencehigh riskhigh throughput screeningin vivoinstrumentmicrobialnew pandemicpathogenrecruitresponseskillssmall molecule inhibitorvaccine developmentweb pageweb portal
项目摘要
PROJECT ABSTRACT (Core 3/C3ResearchSupport@HTRL)
The Howard T. Ricketts Laboratory (HTRL) takes pride in its mission to provide a safe and secure environment
for cutting-edge Biodefense and Emerging Infectious Diseases research, under the support and supervision of
professionals with over 20 years of experience and under the umbrella of Core 3
(C3ResearchSupport@HTRL). The three aims of C3ResearchSupport@HTRL are to: (1) offer professional
research services for the isolation and characterization of a wide range of RG3/Select Agent pathogens (sub-
core C3Microbiology@HTRL); (2) offer professional research services in animal modelling of infection (sub-
core C3AnimalModels@HTRLB); (3) offer hands-on A/BSL3 training to Core 3 Users (sub-core
C3Training@HTRL). All these services will be advertised on the HTRL web page and will be rendered
following free consultation. C3ResearchSupport@HTRL draws on the extensive expertise of Drs. Ahmed and
Khader (Mycobacterium tuberculosis), Glenn Randall (RNA viruses) and Dominique Missiakas (Bacillus
anthracis, Yersinia pestis, Rickettsia sp.) at the University of Chicago. C3ResearchSupport@HTRL will
operate in collaboration with the RBL network, drawing on the expertise of 11 sister laboratories to provide
broad research support, implement contingency plans, and ensure a prompt response in the event of imminent
health threats to the nation. Briefly, C3Microbiology@HTRL will provide high-end technologies and expertise
toward the isolation and characterization of RG3 pathogens (biochemical, genetic, phenotypic
characterizations including antibiotic resistance profiles), the standardization of growth assays to test small
molecule inhibitors, the study of pathogen interactions with host cells. C3AnimalModels@HTRL will provide
standardized, high quality small animal models of infection for the development of countermeasures and for the
study of host responses. C3Training@HTRL will offer Users of Core 3 an opportunity to receive basic
instructions on biosafety, biosecurity, regulatory processes for the handling of high-risk pathogens, SOPs, and
safe laboratory practice in BSL3. C3ResearchSupport@HTRL aims to provide pristine expertise to support
research in response to new pandemics or biodefense threats on our nation or world-wide.
项目摘要(核心3/C3ResearchSupport@HTRL)
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Dominique M. Missiakas其他文献
Dominique M. Missiakas的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Dominique M. Missiakas', 18)}}的其他基金
Optimal adjuvant/antigen formulation toward a Staphylococcus aureus human vaccine
金黄色葡萄球菌人疫苗的最佳佐剂/抗原配方
- 批准号:
10383513 - 财政年份:2022
- 资助金额:
$ 78.33万 - 项目类别:
Development of a Vaccine for Staphylococcal Infections
葡萄球菌感染疫苗的开发
- 批准号:
10255984 - 财政年份:2021
- 资助金额:
$ 78.33万 - 项目类别:
Determinants of plague susceptibility and resistance
鼠疫易感性和抵抗力的决定因素
- 批准号:
10245980 - 财政年份:2020
- 资助金额:
$ 78.33万 - 项目类别:
Antibody therapy of MRSA colonization and infection
MRSA 定植和感染的抗体治疗
- 批准号:
10307576 - 财政年份:2019
- 资助金额:
$ 78.33万 - 项目类别:
Antibody therapy of MRSA colonization and infection
MRSA 定植和感染的抗体治疗
- 批准号:
10525253 - 财政年份:2019
- 资助金额:
$ 78.33万 - 项目类别:
Molecular basis and intervention of Staphylococcus aureus agglutination
金黄色葡萄球菌凝集的分子基础及干预
- 批准号:
8817809 - 财政年份:2014
- 资助金额:
$ 78.33万 - 项目类别:
Molecular basis and intervention of Staphylococcus aureus agglutination
金黄色葡萄球菌凝集的分子基础及干预
- 批准号:
8816265 - 财政年份:2014
- 资助金额:
$ 78.33万 - 项目类别:
Molecular basis and intervention of Staphylococcus aureus agglutination
金黄色葡萄球菌凝集的分子基础及干预
- 批准号:
9180674 - 财政年份:2014
- 资助金额:
$ 78.33万 - 项目类别:
Therapies of infections caused by gram-positive bacteria
革兰氏阳性菌引起的感染的治疗
- 批准号:
8448669 - 财政年份:2013
- 资助金额:
$ 78.33万 - 项目类别:
相似海外基金
Ecological and Evolutionary Drivers of Antibiotic Resistance in Patients
患者抗生素耐药性的生态和进化驱动因素
- 批准号:
EP/Y031067/1 - 财政年份:2024
- 资助金额:
$ 78.33万 - 项目类别:
Research Grant
Collaborative Research: Leveraging the interactions between carbon nanomaterials and DNA molecules for mitigating antibiotic resistance
合作研究:利用碳纳米材料和 DNA 分子之间的相互作用来减轻抗生素耐药性
- 批准号:
2307222 - 财政年份:2024
- 资助金额:
$ 78.33万 - 项目类别:
Standard Grant
Molecular Epidemiology of Antibiotic Resistance in Clostridioides difficile
艰难梭菌抗生素耐药性的分子流行病学
- 批准号:
502587 - 财政年份:2024
- 资助金额:
$ 78.33万 - 项目类别:
Collaborative Research: Leveraging the interactions between carbon nanomaterials and DNA molecules for mitigating antibiotic resistance
合作研究:利用碳纳米材料和 DNA 分子之间的相互作用来减轻抗生素耐药性
- 批准号:
2307223 - 财政年份:2024
- 资助金额:
$ 78.33万 - 项目类别:
Standard Grant
The roles of a universally conserved DNA-and RNA-binding domain in controlling MRSA virulence and antibiotic resistance
普遍保守的 DNA 和 RNA 结合域在控制 MRSA 毒力和抗生素耐药性中的作用
- 批准号:
MR/Y013131/1 - 财政年份:2024
- 资助金额:
$ 78.33万 - 项目类别:
Research Grant
Determining structural dynamics of membrane proteins in their native environment: focus on bacterial antibiotic resistance
确定膜蛋白在其天然环境中的结构动力学:关注细菌抗生素耐药性
- 批准号:
MR/X009580/1 - 财政年份:2024
- 资助金额:
$ 78.33万 - 项目类别:
Fellowship
CAREER: Systems Microbiology and InterdiscipLinary Education for Halting Environmental Antibiotic Resistance Transmission (SMILE HEART)
职业:阻止环境抗生素耐药性传播的系统微生物学和跨学科教育(SMILE HEART)
- 批准号:
2340818 - 财政年份:2024
- 资助金额:
$ 78.33万 - 项目类别:
Continuing Grant
Reinforcing the battle at the bacterial cell wall: Structure-guided characterization and inhibition of beta-lactam antibiotic resistance signalling mechanisms
加强细菌细胞壁的战斗:β-内酰胺抗生素耐药信号机制的结构引导表征和抑制
- 批准号:
480022 - 财政年份:2023
- 资助金额:
$ 78.33万 - 项目类别:
Operating Grants
The spread of antibiotic resistance in bacteria-plasmid networks
抗生素耐药性在细菌-质粒网络中的传播
- 批准号:
BB/X010473/1 - 财政年份:2023
- 资助金额:
$ 78.33万 - 项目类别:
Fellowship
An RNA Nanosensor for the Diagnosis of Antibiotic Resistance in M. Tuberculosis
用于诊断结核分枝杆菌抗生素耐药性的 RNA 纳米传感器
- 批准号:
10670613 - 财政年份:2023
- 资助金额:
$ 78.33万 - 项目类别: